T. Rowe Price Associates, Inc. 13D and 13G filings for DexCom, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | DexCom, Inc. DXCM | T. Rowe Price Associates, Inc. | 8,557,216 2.200% | -9,771,056![]() (-53.31%) | Filing |